Exos TFP Holdings’s Aspire Biopharma ASBP Stock Holding History

Exos TFP Holdings’s Portfolio ASBP Stock Details ASBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$1.63M	Hold	125	–	–	1.01%	52
2023 Q3	$1.62M	Hold	125	–	–	0.88%	53
2023 Q2	$1.56M	Buy	+125	New	+$1.57M	0.77%	59

Other funds holding ASBP

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Arena Investors Purchase, New York $12.5M AUM 0.27% 1-Year Est. Return

Hudson Bay Capital Management

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

Exos TFP Holdings's ASBP Position: Q4 2023 in Review

Exos TFP Holdings held its Aspire Biopharma (ASBP) position steady in Q4 2023 at 125 shares worth $1.63M. The position accounts for 1.01% of the portfolio, ranked #52.

Exos TFP Holdings first reported a position in ASBP in Q2 2023 and has held it in 3 quarters since. 19 funds tracked by Wall St. Rank hold ASBP as of Q4 2023.

Exos TFP Holdings held 125 shares of Aspire Biopharma worth $1.63M as of Q4 2023.
Exos TFP Holdings left its Aspire Biopharma share count unchanged in Q4 2023.
Aspire Biopharma made up 1.01% of Exos TFP Holdings's portfolio in Q4 2023, its #52 holding.
Exos TFP Holdings first reported a position in Aspire Biopharma in Q2 2023 and has held it in 3 quarters since.
19 funds tracked by Wall St. Rank held Aspire Biopharma as of Q4 2023.

Based on Exos TFP Holdings's 13F filing for Q4 2023, filed 14 Feb 2024.